A double-blind, placebo controlled multi-centre study to evaluate the effects of topical Oxytocin on vaginal atrophy in postmenopausal women.

Trial Profile

A double-blind, placebo controlled multi-centre study to evaluate the effects of topical Oxytocin on vaginal atrophy in postmenopausal women.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Jan 2017

At a glance

  • Drugs Oxytocin (Primary)
  • Indications Atrophic vaginitis
  • Focus Therapeutic Use
  • Sponsors Peptonic Medical
  • Most Recent Events

    • 31 Jan 2017 Last checked against ClinicalTrials.gov record.
    • 16 Nov 2011 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database record.
    • 15 Sep 2011 Additional trial identifiers (NCT01432470, OxyPeP001), trial status (completed) and trial centres identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top